MENU
INZY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Inozyme Pharma (INZY) Ownership - Who owns Inozyme Pharma?
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function... Show more
Profile
Industry
N/A
Address
321 Summer Street
Phone
+1 857 330-4340
Employees
59
Web
https://www.inozyme.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
66.17M
P/E Ratio
N/A
Total Cash
113.09M
Projected Growth
N/A
Total Debt
46.87M
Revenue
N/A
Risk (Beta)
1.46
Dividend Yield
N/A
Total Cash/Share
1.76
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
INZY
Capitalization
66.2M
P/E Ratio
N/A
Risk (Beta)
1.46
Dividend Yield
N/A
Total Cash
113M
Total Cash/Share
1.76
Total Debt
46.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
57.8M
P/B Ratio
1.14
Cash Flow
N/A
Earnings
-1.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
3.56
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-95.72M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-62.97
Shares Held By Institutions
161M
Shares Outstanding - Current
64.2M
Total Liabilities
65.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-64.617
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the research and development of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Summer Street
Phone
+1 857 330-4340
Employees
59
Web
https://www.inozyme.com